Edwards Lifesciences Corporation General and Administrative Costs in Inventory, Amount Remaining
Edwards Lifesciences Corporation (EW) had General and Administrative Costs in Inventory, Amount Remaining of $36.90 million as of 2025-12-31, per its 10-K filed 2026-02-25.
Financial Statements › Notes › Inventory › General and Administrative Costs in Inventory
us-gaap:GeneralAndAdministrativeCostsInInventoryAmountRemaining · last filed 2026-02-25
- 2025-12-31: General and Administrative Costs in Inventory, Amount Remaining $36.90M.
- 2024-12-31: General and Administrative Costs in Inventory, Amount Remaining $44.00M.
- 2023-12-31: General and Administrative Costs in Inventory, Amount Remaining $36.30M; General and Administrative Costs in Inventory, Amount Remaining as first filed $45.70M.
- 2022-12-31: General and Administrative Costs in Inventory, Amount Remaining $43.70M.
| Period end | General and Administrative Costs in Inventory, Amount Remaining | General and Administrative Costs in Inventory, Amount Remaining as first filed |
|---|---|---|
| 2025-12-31 | $36.90M 10-K · filed 2026-02-25 | |
| 2024-12-31 | $44.00M 10-K · filed 2026-02-25 | |
| 2023-12-31 | $36.30M 10-K · filed 2025-02-28 | $45.70M 10-K · filed 2024-02-12 |
| 2022-12-31 | $43.70M 10-K · filed 2024-02-12 | |
| 2021-12-31 | $33.70M 10-K · filed 2023-02-13 | |
| 2020-12-31 | $30.70M 10-K · filed 2022-02-14 | |
| 2019-12-31 | $22.80M 10-K · filed 2021-02-12 | |
| 2018-12-31 | $18.30M 10-K · filed 2020-02-14 | |
| 2017-12-31 | $16.00M 10-K · filed 2019-02-15 | |
| 2016-12-31 | $13.00M 10-K · filed 2018-02-16 | $22.90M 10-K · filed 2017-02-17 |
| 2015-12-31 | $16.80M 10-K · filed 2017-02-17 | |
| 2014-12-31 | $17.50M 10-K · filed 2016-02-19 | |
| 2013-12-31 | $15.00M 10-K · filed 2015-02-20 | $14.30M 10-K · filed 2014-02-28 |
| 2012-12-31 | $15.10M 10-K · filed 2014-02-28 | |
| 2011-12-31 | $15.90M 10-K · filed 2013-02-28 | |
| 2010-12-31 | $12.00M 10-K · filed 2012-02-27 | |
| 2009-12-31 | $10.30M 10-K · filed 2011-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| STERIS plc (STE) | Ireland | $20.343B | 25.49 |
| ZIMMER BIOMET HOLDINGS, INC. (ZBH) | United States | $17.103B | 20.66 |
| ALIGN TECHNOLOGY INC (ALGN) | United States | $10.346B | 29.06 |
| MSA Safety Inc (MSA) | United States | $7.023B | 21.47 |
| ESTABLISHMENT LABS HOLDINGS INC. (ESTA) | $1.954B | -65.76 | |
| Cadre Holdings, Inc. (CDRE) | United States | $1.123B | 33.88 |
| Enovis CORP (ENOV) | United States | $1.053B | -1.18 |
| Anteris Technologies Global Corp. (AVR) | United States | $0.746B | |
| Sanara MedTech Inc. (SMTI) | United States | $0.323B | -6.81 |
| Inogen Inc (INGN) | United States | $0.139B | -7.00 |